Please login to the form below

Not currently logged in
Email:
Password:

US pharma

This page shows the latest US pharma news and features for those working in and with pharma, biotech and healthcare.

Tit for tat as PBMs blame pharma for high drug prices

Tit for tat as PBMs blame pharma for high drug prices

US Senate turns its spotlight on 'middlemen'. Pharmacy benefit managers (PBMs) were challenged by the US Senate Finance Committee on their pricing practices yesterday, but laid the blame on pharmaceutical manufacturers. ... The pharma executives directed

Latest news

More from news
Approximately 7 fully matching, plus 696 partially matching documents found.

Latest Intelligence

  • The Orkambi blame game The Orkambi blame game

    The three-hour evidence session also bore some resemblance to the recent interrogation of seven big pharma CEOs by a US Senate committee enquiry into US drug prices, albeit with just ... NHS England accusing Vertex of being an“extreme outlier” and

  • The handover: Pfizer reshapes itself for a new era The handover: Pfizer reshapes itself for a new era

    For the US market, this would formerly have been seen as an outrageous idea, and US pharma CEOs and industry lobby group PhRMA have opposed the move. ... These battles over pricing and access in the US market remain among the biggest priorities for

  • China: AstraZeneca’s new engine for growth and innovation China: AstraZeneca’s new engine for growth and innovation

    So how long before China eclipses the European market as the second most important behind the US? ... AstraZeneca is just one of several multinational pharma companies working with China’s homegrown tech companies.

  • Biopharma's Future: Made in China Biopharma's Future: Made in China

    to encourage a home-grown pharma industry, as well as investment from multinational giant. ... Big pharma reaps the benefits. There is no question that established US and European big pharma companies are also reaping the benefits of the new China boom.

  • Cutting through the noise

    When pharma companies sponsor educational programmes they usually aim to:. Fill gaps in clinical knowledge and improve patient outcomes. ... These principles enable us to spark creativity by engendering questions such as: ‘how can we give the learner

More from intelligence
Approximately 0 fully matching, plus 50 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 60 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 14 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Say Communications

Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics